AR and benign prostatic hyperplasia: Since DHT may increase the incidence of benign prostate hyperplasia due to the proliferative activity in the prostate [73], alternative androgens that have almost no effect on the prostate such as selective androgen receptor modulators (SARMs) [74] can be tested to see whether they can replicate the effects of DHT in ALS.